FAQ

 

What is the purpose of the platform?

 

The UK COVID-19 MedTech Analytics Platform designed to serve as a comprehensive database of the most relevant entities, technologies, and developments in the COVID-19 MedTech ecosystem, aggregating, profiling and visualizing the companies, organizations, technologies and funding and support bodies at the forefront of neutralizing the COVID-19 pandemic and ensuring the health and safety of UK citizens during this time of unprecedented crisis. The platform aims to cover all major sectors and relevant activities in the UK COVID-19 MedTech landscape from science to technology, R&D, treatment, diagnostic and vaccine development, and practical applications.

 

What makes it different from other databases?

 

Firstly, its scope. The platform aggregates, categorizes and visualizes data across the entire COVID MedTech ecosystem, all the way from basic science toward R&D and practical applications, categorizing and individually profiling companies, investors, scientists, labs, universities, R&D hubs, funding agencies, clinical trials, patents, and scientists papers. It is designed to serve as a one-stop informational resource for current developments in the COVID MedTech ecosystem across its entire scope, comprehensively profiling and categorizing entities, individuals and technologies within the global COVID MedTech landscape both by sector and practical application, as well as by geographical region.

 

Secondly, its scale. In collecting both third-party lists and manually-curated databases, the platform is able to offer visualized, categorized lists, MindMaps and individual profiles on a remarkably large number of entities, individuals and technologies. The platform is in an ongoing state of expansion, and its scale is intended to continue growing. 

 

Thirdly, its use of the sophisticated IT-solutions and Interactive MindMap and Data Visualization capabilities that Deep Knowledge Analytics has developed over the past several years in order to position itself as the leader of quantitative and multidimensional Deeptech and Frontier Technology analytics, enabling users of the platform to gain a deeper understanding of the full landscape in any given scientific, technological, industrial or regional category in a more efficient manner.

 

Does it have additional features not present in your Global COVID-19 MedTech Analytical IT-Platform?

 

Yes. Notably, the platform features a number of expansions and enhancements in comparison to its predecessor, Deep Knowledge Group’s Global COVID-19 MedTech Analytics IT-Platform. In particular, the new UK-focused database places increased emphasis on the funding and support side of the MedTech ecosystem, profiling 200 governmental and non-governmental bodies providing either monetary or in-kind support to entities working to neutralize and stabilize the COVID-19 pandemic, as well as a subset of bodies which are not yet providing major COVID-19 funding and support, but whose core missions and driving mandates Deep Knowledge Group analysts considers would allow it. 

 

The platform also features interactive mindmaps that visualize connections between different types of entities within the UK COVID-19 MedTech Ecosystem, making it easy for decision makers and private and public sector professionals with a vested interest in neutralizing the UK COVID-19 pandemic to obtain a precise overview of the funding and collaboration landscape, and to determine where funding bodies are providing their support, and which companies are actively collaborating with which exact labs universities and hubs.

 

Why have you focused on the UK?

 

As with many other regions, the UK has a long way to go in terms of improving its current COVID-19 situation, with clear risks and critical bottlenecks that should be optimized moving forward to maximize positive health and economic outcomes now and in the post-COVID era, especially as the fundamental nature of the pandemic begins to shift away from preparation toward relaxing lockdown mandates in a relevant and strategic manner, and optimizing economic resilience and sustainability without sacrificing public health and safety. 

 

However, the data contained, categorized and visualized in Deep Knowledge Group’s newest COVID-19 IT-Platform demonstrates that the UK has a very well developed COVID-19 MedTech ecosystem as well, which suggests that the region’s high infection and mortality rate, and its comparatively low safety ranking, are not the results of its innate potential and capacity for COVID-19 success, but rather a result of its specific past choices and policy, and the the nation has the core resources to reverse its current COVID-19 trajectory.

 

While Deep Knowledge Analytics is also actively working on the development of several other geography-specific COVID-19 MedTech Analytics IT-Platforms, the launch of the UK component has been prioritized given the higher severity of the pandemic within the region at the present time, and was developed in order to provide proactive government representatives, companies, labs and scientists with the full scope of information required to accelerate the neutralization of negative COVID-19 outcomes within the UK.

 

What are your future plans for the platform?

 

The platform is intended to be used on an ongoing basis as an analytical toolset for interested parties to derive action-oriented insights and answers to questions relating to the current situation of COVID-19 (such as vaccine and treatment development, for example, or the currently available scope of preventive technologies), potential industry partners, and more. 

 

The database is in a continuous state of development, and Deep Knowledge Group intends to expand on an ongoing basis its breadth and depth, the scale and scope of its scientific and technological sectors, the number of specific regions it covers, and the overall quantity of entities that it profiles and visualizes. 

 

In addition to this, the group will also be unveiling enhanced features, including extensive filter and search functions, allowing everybody from the general public to responsible decision makers to use the platform to derive action-based answers and insights to key questions at the heart of national strategic decision making to optimize outcomes in the wake of the current global COVID-19 pandemic.

 

How can I suggest an addition or modification to the platform?

 

In the longer term the platform is intended to serve as a distributed knowledge system, crowdsourcing additional data from relevant experts. While Deep Knowledge Group has already aggregated data from multiple reputable public sources and qualified experts within its existing network, we remain open to contributions from experts and specialists interested in expanding the scope and reach of the platform. Interested individuals can submit new entries for review by using the following form:

https://docs.google.com/forms/d/e/1FAIpQLSevOx0HLE4yOnHqEdoWqDml_tyt1nRtRJpY7IPHMhbPpc81WA/viewform

​